Star Therapeutics company information, Employees & Contact Information

Star Therapeutics Announces Oversubscribed $125 Million Series D Financing Yahoo Finance

GordonMD Global Investments® Backs Star Therapeutics in $125 Million Series D Financing Business Wire

Star Therapeutics raises $125M as bleeding disorder therapy enters Phase III FirstWord Pharma

Fenwick Represents Star Therapeutics in Oversubscribed $125M Series D Funding fenwick.com

Star Therapeutics: $125 Million Series D Raised For Developing Antibodies For Bleeding Disorders Pulse 2.0

Star Therapeutics gains $125m Series D funds to develop pipeline Yahoo Finance

Pushing the Limits for More Treatment Options for Von Willebrand Disease Docwire News

Starton Therapeutics Presents Positive Data from Phase 1b GlobeNewswire

Sanofi Ventures, Viking Global lead Star Therapeutics’ $125m Series D By Investing.com Investing.com South Africa

Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD) Business Wire

Star Therapeutics launches Vega, growing its galaxy of drug startups BioPharma Dive

Star Therapeutics Lands $90M to Expand Its Drug Discovery Universe MedCity News

Sino Biopharmaceutical Completes Acquisition of F-Star Therapeutics; Long-Run Global Strategy Intact Morningstar

Asked and Answered: Follow the Biology Inside Precision Medicine

F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals PR Newswire

Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024 Yahoo Finance

Star Therapeutics emerges with plans to treat rare diseases through a solar system of drug companies BioPharma Dive

Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies Business Wire

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer Business Wire

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma Yahoo Finance

invoX Pharma to Acquire F-star Therapeutics citybiz

F-star, an invoX Company, Announces Strategic Collaboration GlobeNewswire

F-star Therapeutics Announces a License Agreement with GlobeNewswire

Star Therapeutics Starts a Family with Electra BioSpace

F-star charts new path, splitting from invoX after 2023's $161M acquisition Fierce Biotech

F-star Therapeutics Announces License Agreement with GlobeNewswire

invoX Pharma to Acquire F-star Therapeutics, Inc. a GlobeNewswire

Lowenstein Represents Spring Bank Pharmaceuticals in Combination With F-star Therapeutics Lowenstein Sandler LLP

Verismo Therapeutics Announces Opening of Second Clinical Site for STAR-101 Phase 1 Trial PR Newswire

Takeda enters agreement with F-star Therapeutics to license bispecific antibody Drug Target Review

Verismo Therapeutics Provides Updates on Upcoming Poster Presentation at ASCO 2025 PR Newswire

Spring Bank Pharmaceuticals and F-star Therapeutics Agree GlobeNewswire

F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors GlobeNewswire

CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment Business Wire

Takeda adds another F-Star collab to constellation, this time for $1B in biobucks Fierce Biotech

Electra, one of 2 Star biotechs, snags $84M to apply brakes to 'immune system haywire' Fierce Biotech

Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025 Business Wire

PESG Report: Silexion Therapeutics’ Systemic Delivery Breakthrough Positions Company as Rising Star in The Multi-Billion Dollar Precision Oncology Market Yahoo Finance

Ring Therapeutics Announces New Strategic Partnerships with GlobeNewswire

Sino Biopharm/F-Star Therapeutics: U.S., UK Coordinate National Security Reviews of Controversial Deal The Capitol Forum

Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma PR Newswire

Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology Business Wire

Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform PR Newswire

invoX Pharma to acquire F-star Therapeutics The Pharma Letter

Extracellular vesicles: a rising star for therapeutics and drug delivery Journal of Nanobiotechnology

Merck KGaA takes 4th option on Big Pharma darling F-star's bispecific immunotherapies Fierce Biotech

F-star shoots for the moon with massive $1.35B J&J biobucks deal for 5 bispecifics Fierce Biotech

F-star Therapeutics bags $1.5 billion deal with Janssen The Pharma Letter

AstraZeneca becomes latest Big Pharma to get caught in F-Star STING with $12M upfront deal Fierce Biotech

Star Therapeutics oversubscribed $125 million series D financing financing co-led by Sanofi Ventures & Viking Global Investors MarketScreener

Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis Business Wire

Ring Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to Establish Gene Therapy R&D Efforts in Singapore, a Growing Global Biotech Hub BioSpace

Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma Business Wire

'I guarantee you'll never get bored': Unique approach lands biotech spinout $84M The Business Journals

Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward TipRanks

Another star is born: Vega Therapeutics targets protein S for bleeding disorders BioWorld MedTech

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore PR Newswire

Sanofi Ventures, Viking Global lead Star Therapeutics’ $125m Series D Investing.com India

F-star Therapeutics (FSTX) Stock Price, News & Analysis MarketBeat

F-star set to land Nasdaq listing through Spring Bank merger Fierce Biotech

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors Business Wire

Biogen Announces Topline Results from Phase 3 Gene Therapy Study in Choroideremia Biogen

Juno Therapeutics acquired by Celgene for $9B in dramatic deal for rising biotech star GeekWire

Denali acquires F-star's blood-brain barrier bispecific antibody tech in deal worth up to $471M Fierce Biotech

Star Therapeutics Closes $125 Million Series D Financing Global Legal Chronicle